Galactosemia: Difference between revisions

Jump to navigation Jump to search
Sujaya97 (talk | contribs)
Jose Loyola (talk | contribs)
No edit summary
 
(34 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Galactosemia}}
{{Galactosemia}}
{{CMG}}; {{AE}} {{DD}}
{{CMG}}; {{AE}} {{Sujaya}}


{{SK}} Classic galactosemia, galactokinase deficiency
{{SK}} Classic galactosemia, galactokinase deficiency
Line 8: Line 8:


==[[Galactosemia historical perspective|Historical Perspective]]==
==[[Galactosemia historical perspective|Historical Perspective]]==
__NOTOC__
{{Galactosemia}}
{{CMG}}; {{AE}}


==[[Galactosemia classification|Classification]]==
==[[Galactosemia classification|Classification]]==
__NOTOC__
{{Galactosemia}}
{{CMG}}; {{AE}}
==Overview==
[[Galactosemia]] consists of four types of [[disorders]] resulting from abnormal activity of the [[enzymes]] involved in [[galactose]] [[metabolism]]. Type I/ Classical is the most serious form of the [[disease]].
==Types==
[[Galactosemia]] refers to a group of [[autosomal recessive]] disorders of [[galactose]] [[metabolism]]. They are classified into the following types based on the enzymatic activity <ref name="pmid33562227">{{cite journal| author=Banford S, McCorvie TJ, Pey AL, Timson DJ| title=Galactosemia: Towards Pharmacological Chaperones. | journal=J Pers Med | year= 2021 | volume= 11 | issue= 2 | pages=  | pmid=33562227 | doi=10.3390/jpm11020106 | pmc=7914515 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33562227  }} </ref>
===Type I/Classical===
Severe deficiency or absence of the [[Galactose-1-phosphate uridyl transferase]] [[enzyme]] of the [[Leloir pathway]] in the [[red blood cells]].<ref name="pmid28281081">{{cite journal| author=Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I| title=Sweet and sour: an update on classic galactosemia. | journal=J Inherit Metab Dis | year= 2017 | volume= 40 | issue= 3 | pages= 325-342 | pmid=28281081 | doi=10.1007/s10545-017-0029-3 | pmc=5391384 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28281081  }} </ref>. This is the most severe and potentially lethal type.
===Type II===
Mutations in the [[gene]] encoding for the enzyme [[galactokinase]]<ref name="pmid15526155">{{cite journal| author=Holden HM, Thoden JB, Timson DJ, Reece RJ| title=Galactokinase: structure, function and role in type II galactosemia. | journal=Cell Mol Life Sci | year= 2004 | volume= 61 | issue= 19-20 | pages= 2471-84 | pmid=15526155 | doi=10.1007/s00018-004-4160-6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15526155  }} </ref>
===Type III===
Alterations in the [[gene]] coding for [[epimerase]] enzyme.<ref name="pmid16611573">{{cite journal| author=Timson DJ| title=The structural and molecular biology of type III galactosemia. | journal=IUBMB Life | year= 2006 | volume= 58 | issue= 2 | pages= 83-9 | pmid=16611573 | doi=10.1080/15216540600644846 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16611573  }} </ref> This is the mildest type.
===Type IV===
This type has only been discovered recently. Abnormal changes in the [[galactose mutatrose]] enzyme, encoded by the GALM [[gene]],  have been proven to cause the disorder. <ref name="pmid33181226">{{cite journal| author=Banford S, Timson DJ| title=The structural and molecular biology of type IV galactosemia. | journal=Biochimie | year= 2021 | volume= 183 | issue=  | pages= 13-17 | pmid=33181226 | doi=10.1016/j.biochi.2020.11.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33181226  }} </ref>
===


==[[Galactosemia pathophysiology|Pathophysiology]]==
==[[Galactosemia pathophysiology|Pathophysiology]]==
Line 45: Line 19:
==[[Galactosemia epidemiology and demographics|Epidemiology and Demographics]]==
==[[Galactosemia epidemiology and demographics|Epidemiology and Demographics]]==


==[[Galactosemia risk factors|Risk Factors]]==
==[[Galactosemia screening|Screening]]==


==[[Galactosemia screening|Screening]]==  
==[[Galactosemia Risk factors|Risk factors]]==


==[[Galactosemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Galactosemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==[[Galactosemia diagnosis|Diagnosis]]==
[[Galactosemia history and symptoms|History and Symptoms]] | [[Galactosemia physical examination|Physical Examination]] | [[Galactosemia laboratory findings|Laboratory Findings]] | [[Galactosemia electrocardiogram|Electrocardiogram]] | [[Hashiomoto's thyroiditis chest x ray|Chest X Ray]] | [[Galactosemia CT|CT]] | [[Galactosemia MRI|MRI]] | [[Galactosemia echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Galactosemia other imaging findings|Other Imaging Findings]] | [[Galactosemia other diagnostic studies|Other Diagnostic Studies]]
 
[[Galactosemia history and symptoms|History and Symptoms]] | [[Galactosemia physical examination|Physical Examination]] | [[Galactosemia laboratory findings|Laboratory Findings]] |[[Galactosemia electrocardiography|Electrocardiography]]|[[Galactosemia chest xray| Chest XRay]]| [[Galactosemia ct scan|CT Scan]]| [[Galactosemia MRI|MRI]]|[[Galactosemia Echocardiography and Ultrasound|Echocardiography and Ultrasound]]| [[Galactosemia other imaging|Other Imaging]]| [[Galactosemia other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==[[Galactosemia treatment|Treatment]]==


[[Galactosemia medical therapy|Medical Therapy]] | [[Galactosemia surgery|Surgery]] | [[Galactosemia primary prevention|Primary Prevention]] | [[Galactosemia secondary prevention|Secondary Prevention]] | [[Galactosemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Galactosemia future or investigational therapies|Future or Investigational Therapies]]
[[Galactosemia medical therapy|Medical Therapy]] | [[Galactosemia surgery|Surgery]] | [[Galactosemia primary prevention|Primary Prevention]] | [[Galactosemia secondary prevention|Secondary Prevention]] | [[Galactosemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Galactosemia future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==[[Galactosemia case studies|Case Studies]]==
[[Galactosemia case study one|Case #1]]
[[Galactosemia case study one|Case #1]]



Latest revision as of 15:04, 18 August 2022

Galactosemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Galactosemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Galactosemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Galactosemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Galactosemia

CDC on Galactosemia

Galactosemia in the news

Blogs on Galactosemia

Directions to Hospitals Treating Galactosemia

Risk calculators and risk factors for Galactosemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Synonyms and keywords: Classic galactosemia, galactokinase deficiency

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Galactosemia from other Diseases

Epidemiology and Demographics

Screening

Risk factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings |Electrocardiography| Chest XRay| CT Scan| MRI|Echocardiography and Ultrasound| Other Imaging| Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Metabolic pathology

Template:WikiDoc Sources